Second CAR-T Cell Therapy Approved by FDA – JD Supra (press release)
|
Second CAR–T Cell Therapy Approved by FDA
JD Supra (press release) Less than two months after approving the first gene therapy for use in the U.S., that of Novartis's Kymriah for treatment of pediatric patients with acute lymphoblastic leukemia (ALL), the FDA has approved a second single-infusion CAR–T cell therapy … |
